Records containing: Hepatitis C
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2018-05-03Strategic Screening for Infectious Diseases (Tuberculosis, HIV, HBV, HCV) Amongst Migrants in France
-
CLINICAL_TRIALS study record update · 2018-04-30Sustained Viral Response Rate in 50 Subjects With Cirrhosis Due to Hepatitis C, Genotype 1, Treated With 12 Weeks of Sofosbuvir, Ledipasvir and Ribavirin
-
CLINICAL_TRIALS study record update · 2018-04-18HCV Cure and Kidney Health: A Prospective, Observational Cohort Study of HCV Genotype 1 and 4 Infected Adults With and Without HIV Infection
-
CLINICAL_TRIALS study record update · 2018-04-17Improving Treatment and Liver Fibrosis Outcomes With Metformin in HCV-HIV Co-infected and HCV Mono-infected Patients With Insulin Resistance.
-
CLINICAL_TRIALS study record update · 2018-04-10The Treatment And Prevention (TAP) Study: Treating People Who Inject Drugs (PWID) in Community-based Settings Using a Social Network Approach
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2018-04-09The Pathogenesis of Hepatitis C Virus Vertical Transmission
-
CLINICAL_TRIALS study record update · 2018-04-05An Open-label Pilot Study to Determine the Tolerability and Efficacy of Fixed-dose Grazoprevir/Elbasvir Treatment in Hepatitis C Uninfected Recipients of Renal Transplants From Hepatitis C Infected Deceased Donors
-
CLINICAL_TRIALS study record update · 2018-03-30A Pilot Trial of Directly Observed Anti HCV Therapy Supported With Contingency Management in a Population on Opiate Substitute Therapy
-
CLINICAL_TRIALS study record update · 2018-03-29A Phase 3 Evaluation of Daclatasvir and Sofosbuvir With Ribavirin in Cirrhotic Subjects With Genotype 3 Chronic Hepatitis C Infection
-
CLINICAL_TRIALS study record update · 2018-03-20A Phase II, Randomized, Open-Label Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-3682B (MK-5172 + MK-3682 + MK-8408 Fixed Dose Combination (FDC)) in Subjects With Chronic HCV GT1 or GT3 Infection Who Have Failed a Direct Acting Antiviral Regimen
-
CLINICAL_TRIALS study record update · 2018-03-07The Use of MRI Apparent Diffusion Coefficient Value (ADC Value) to Assess Liver Cirrhosis in Hepatitis C Patients: Observational Case Control Study
-
CLINICAL_TRIALS study record update · 2018-02-15Retrospective Efficacy and Safety Study With Elbasvir 50 mg/Grazoprevir 100 mg in HCV-infected Patients With Chronic Kidney Disease Stage 4-5 During the French Temporary Authorization for Use (ATU) Program: Data From Real-life
-
CLINICAL_TRIALS study record update · 2018-02-15Phase II Trial of Retreatment Strategies for Difficult-to-Treat Hepatitis C Virus (HCV)-Infected Individuals Who Have Failed Prior Direct Acting Antiviral (DAA)-Based Regimens
-
CLINICAL_TRIALS study record update · 2018-02-14A Multicenter, Open Label, Pilot Study of MK-5172 (Grazoprevir)/MK-8742 (Elbasvir) Without Ribavirin for 12 Weeks in G1b and G4 Patients With HCV-related Cryoglobulinemic Nephropathy
-
CLINICAL_TRIALS study record update · 2018-01-30Prevalence of IL28B Polymorphism in Hepatitis C Patients in Singapore and Its Effect on the Outcome of Hepatitis C Treatment
-
CLINICAL_TRIALS study record update · 2018-01-18Impact of Interferon-free Treatment for Hepatitis C Virus (HCV) on Blood Cells and Factors in Blood
-
CLINICAL_TRIALS study record update · 2018-01-18Improving Blood Safety and HIV Testing in Brazil: a Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2018-01-09Ribavirin, Its Dosing Regime
-
CLINICAL_TRIALS study record update · 2017-12-27A Phase 3 Randomized, Open-Label, Study to Evaluate the Safety and Efficacy of the Combined Single Dose of Dactavira Plus (EPGCG, Sofosbuvir , Daclatasvir & Ribavirin) Versus Sofosbuvir + Daclatasvir + Ribavirin (Part A) and a Single Dose of Dactavira (EPGCG, Sofosbuvir & Daclatasvir) Versus Sofosbuvir + Daclatasvir (Part B) in Egyptian Adults With Chronic Genotype 4 HCV Infection
-
CLINICAL_TRIALS study record update · 2017-12-21A Phase II, Randomized, Open-Label Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172 and MK-3682 With Either MK-8742 or MK-8408 in Subjects With Chronic HCV GT1 and GT2 Infection
-
CLINICAL_TRIALS study record update · 2017-12-13TAC (Treatment Africa Hepatitis C) : Feasibility, Tolerance and Efficacy of Interferon-free, Antiviral Treatment With Sofosbuvir + Ribavirin for the Treatment of Genotype 2 and Sofosbuvir/Ledipasvir for the Treatment of Genotype 1 and 4 Hepatitis C Virus-infected Patients in West and Central Africa
-
CLINICAL_TRIALS study record update · 2017-12-13A Phase 3, Global, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Safety and Efficacy of Sofosbuvir/Velpatasvir/GS-9857 Fixed-Dose Combination for 12 Weeks in Direct-Acting Antiviral-Experienced Subjects With Chronic HCV Infection
-
CLINICAL_TRIALS study record update · 2017-12-08Pre-operative Screening for HIV and Viral Hepatitis B and C: Pilot Study in Stomatology
-
CLINICAL_TRIALS study record update · 2017-12-07Toward Elimination of Hepatitis C Virus (HCV): A Pilot Study Combining HCV and Addiction Treatment of Young Suburban Heroin Users (SHU) That Addresses Barriers to Care
-
CLINICAL_TRIALS study record update · 2017-12-07The Effect of Direct Antiviral Therapy on Hepatitis c Virus-related Thrombocytopenia